Clinical trial
The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment
NCT06681246 is registered in ClinicalTrials.gov with Weizmann Institute of Science as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment
- Lead sponsor
- Weizmann Institute of Science
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 11, 2024
- Completion date
- December 31, 2027
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.